XTX Topco’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $527K | Sell |
37,555
-36,121
| -49% | -$506K | 0.02% | 1064 |
|
2025
Q1 | $1.15M | Buy |
+73,676
| New | +$1.15M | 0.06% | 483 |
|
2024
Q4 | – | Sell |
-47,728
| Closed | -$444K | – | 2265 |
|
2024
Q3 | $444K | Buy |
47,728
+11,262
| +31% | +$105K | 0.03% | 899 |
|
2024
Q2 | $339K | Buy |
36,466
+25,793
| +242% | +$240K | 0.03% | 882 |
|
2024
Q1 | $106K | Sell |
10,673
-135,389
| -93% | -$1.34M | 0.01% | 1354 |
|
2023
Q4 | $472K | Buy |
146,062
+122,602
| +523% | +$396K | 0.1% | 295 |
|
2023
Q3 | $125K | Buy |
+23,460
| New | +$125K | 0.02% | 1152 |
|
2023
Q1 | – | Sell |
-12,222
| Closed | -$181K | – | 1259 |
|
2022
Q4 | $181K | Buy |
+12,222
| New | +$181K | 0.04% | 881 |
|